Jazz Pharmaceuticals plc number of employees

Jazz Pharmaceuticals plc reported 700 employees at December 31, 2022 in its latest annual report, up 0 (0.0%) on the year before. Revenue per employee was $5.2m.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2022	700	+0 (0.0%)	$5.2m	10-K, filed March 1, 2023
December 31, 2021	700	—	$4.4m	10-K, filed March 1, 2022

What the annual reports say

As an innovative biopharmaceutical company, we have over 700 full-time employees — representing approximately 25% of our global workforce — supporting our research and development activities. 2022 annual report
As an innovative biopharmaceutical company, we have over 700 full-time employees — greater than 22% of our global workforce — supporting our research and development activities. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: ELAN vs JAZZ JAZZ vs OGN AMRX vs JAZZ

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Jazz Pharmaceuticals plc's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Jazz Pharmaceuticals plc.